News & Analysis on Clinical Trial Services & Contract Research And Development
Nanostream has introduced an integrated plate changing system designed to meet the increasing demand in high-throughput analytical laboratories. The system also aims to allow users to increase their analytical throughput for a variety of drug...
A new signature genetics tool, which allows doctors to personalise drug therapy, could well have the potential to personalise a patient's drug regimen based on his/her genetic makeup to minimise side effects and maximise drug efficacy.
Germany's Boehringer Ingelheim is claiming the number two spot among the top 20 pharmaceutical companies for 2004 growth, reporting double-digit gains for both revenues and operating profit.
Varian has introduced a nuclear magnetic resonance (NMR) probe that for the first time can be used to determine the molecular structures of proteins and other biomolecules in the solid state.
Thermo Electron has updated its XYZ robotic TriPlus Autosampler (AS) for increased sample throughput for GC and GC/MS applications in the pharmaceutical, food, fragrance and environmental laboratories.
Innodia are to initiate a phase I trial of its lead drug candidate for the treatment of type 2 diabetes with a view to bringing this novel drug to market and the 170 million people affected by the disease, a number that is expected to exceed 300...
Groupe Novasep has provided an update on the structural changes at the company in the wake of its merger with Dynamic Synthesis in January.
The chemicals subsidiary of Germany's Boehringer Ingelheim is expanding its manufacturing capacity for the nasal decongestant phenylephrine hydrochloride to tap into what it said is growing demand worldwide.
Injectable drug delivery specialist West Pharmaceutical Services has develop a system of anticounterfeiting measures for its Flip-Off seals, widely used for injectable drugs that are withdrawn from vials by a syringe.